Stem cell and platelet-rich plasma therapies for equine tendon injuries offer improved healing quality and reduced re-injury rates with direct welfare benefits.
Regenerative therapies for equine tendon injuries represent a genuine welfare advance by improving the quality of repair tissue and reducing re-injury rates. A horse that re-injuries a tendon suffers repeated bouts of acute pain, requires repeated prolonged rehabilitation, and may ultimately be euthanized for unresolvable lameness. Reducing re-injury from 60% to 20% with stem cell therapy translates directly to fewer horses experiencing this repeated welfare harm. The therapies are complementary to — not replacements for — rigorous rehabilitation protocols: biological healing enhancement only benefits horses if combined with appropriate controlled exercise progression that allows organized tissue maturation. Welfare-centered rehabilitation emphasizes return to pain-free function rather than speed of return to competition.